QNRF PR / Sunday, September 19, 2021 / Categories: Announcements Research Outcome Seminar (ROS) Advancing Research in Pediatric Diseases and Conditions The scope and pace of pediatric research discoveries are rooted in our understanding of basic science through to clinical studies, as well as improved technologies, which have advanced disease outcomes in children. Greater advocacy, governance and the imperative to conduct collaborative pediatric clinical trials, have also accelerated change in clinical policies and public health practices. Emerging competitive programs and research priorities at QNRF will continue to build new knowledge critical to child health. For example, the support of genomic approaches and regenerative medicine, has led their rapid integration into the diagnosis of hereditary diseases in children. QNRF’s support of pediatric interventions, recognises that such treatments in adulthood may have limited success. To learn more about this, you are invited to an online seminar which will highlight QNRF’s commitment and continual investment in supporting a broad-based biomedical research in understanding the hereditary and developmental origins of pediatric diseases and conditions in Qatar. The seminar will feature presentations delivered by selected QNRF-funded researchers, who will share the details of their projects in line with Qatar’s National Research Priorities, followed by a panel discussion. More importantly, the ROS will also provide attendees with an opportunity to network, collaborate and share the benefits of their work with other researchers and the public. Time: 10:00 AM – 12:30 PM (Doha Time) Date: Sunday, 26 September 2021 Venue: Online Webinar You can join the seminar directly by clicking here. We look forward to your attendance. Program Schedule Time Topic Presenter 10:00-10.15 Welcome and QNRF’s Portfolio in Pediatric Research Dr. Fatemeh Darakhshan-Rassam Program Manager, Biomedical Science & Health, QNRF 10:15 – 10:25 Keynote Speech Dr. Barbro Fridén Chief Executive Officer, Sidra Medicine Presentations of the Projects 10:25 – 10:40 Understanding the epidemiology, prevalence and genetic mechanisms of diabetes mellitus in children in the State of Qatar Project Number: NPRP10-0206-170370 Prof. Khalid Hussain, Chief of Endocrinology, Sidra Medicine Professor of Pediatrics, WCM-Q 10:40 – 10:55 Towards a systems-level understanding of pediatric Inflammatory Bowel Disease in Qatar: interplay between the immunogenome and the microbiome Project Number: NPRP10-0125-170242 Dr. Souhaila Al Khodor Director of Maternal and Child Health Program, Sidra Medicine 10:55 – 11:10 Microenvironmental targets for restoring anti-tumor immunity in childhood acute leukemias Project Number: NPRP8-2297-3-494 Dr. Chiara Cugno Director of Advanced Cell Therapy Core, Attending Physician Pediatric Hem-Onc, Sidra Medicine 11:10 – 11:25 Building haplotype-resolved denovo genome maps for Qatari family trios with severe developmental disorders as a premium resource to enhance diagnosis & uncover their etiology in the Qatari population Project Number: NPRP10-1219-160035 Dr. Younes Mokrab Principal Investigator in Translational Genetics and Bioinformatics, Sidra Medicine 11:25 – 11:40 PhD - Genotype-Phenotype Correlation in Stargardt Disease Project Number: GSRA6-1-0329-19010 Dr. Saoud Al-Khuzaei PhD Student, Oxford University 11:40 – 11:50 Q & A Session Panel Discussion and Closing Remarks 11:50 – 12:30 Prof. Ibrahim AL-Janahi Professor of Clinical Pediatrics, WCM-Q Chairman and DIO, Department of Pediatric Medicine, Sidra Medicine Dr. Khalid Fakhro Chief Research Officer and Director of Precision Medicine Program, Sidra Medicine Dr. Ahsan Nazeer Division Chief, Child and Adolescent Psychiatry, Sidra Medicine Associate Professor, Clinical Psychiatry, WCM-Q Previous Article GSRA8+: Graduate Sponsorship Research Award International Track Special Call Next Article Launch of the 3rd Cycle of the Food Security Call Print 4987 Rate this article: 5.0